Filing Flows › Comparisons › CSBR vs CHRS
Champions Oncology vs Coherus Oncology: CSBR and CHRS compared
Champions Oncology is the larger company: $15.2M of revenue in its latest quarter (Q1 FY27) against $14.3M for Coherus Oncology (Q2 2026). Coherus Oncology is growing faster (+40% against +9% a year earlier). Champions Oncology is more profitable, with an operating margin of -2.7% against -226.0%.
Where the money goes: CSBR and CHRS
Champions Oncology (CSBR) · Q1 FY27
Champions Oncology, Q1 FY27: revenue $15.2M (+9% year over year), operating margin -2.7%, net loss $426K, operating cash flow −$492K. The chart follows the revenue to costs, profit and cash.
Coherus Oncology (CHRS) · Q2 2026
Coherus Oncology, Q2 2026: revenue $14.3M (+40% year over year), operating margin -226.0%, net loss $20.6M, operating cash flow −$62.1M. The chart follows the revenue to costs, profit and cash.
| Champions Oncology (CSBR) | Coherus Oncology (CHRS) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q2 2026 |
| Revenue | $15.2M | $14.3M |
| Revenue growth, Y/Y | +9% | +40% |
| Operating margin | -2.7% | -226.0% |
| Net earnings | −$426K | −$20.6M |
| Net margin | -2.8% | -144.2% |
| Operating cash flow | −$492K | −$62.1M |
Where the revenue comes from
Champions Oncology
- Pharmacology services: $14.2M (93%)
- TOS data license revenue: $893K (6%)
- Other TOS revenue: $183K (1%)
Coherus Oncology
- Toripalimab: $13.6M (95%)
- Other revenue: $694K (5%)
Questions
Which is bigger, Champions Oncology or Coherus Oncology?
Champions Oncology is the larger company: $15.2M of revenue in its latest quarter (Q1 FY27) against $14.3M for Coherus Oncology (Q2 2026).
Is Champions Oncology or Coherus Oncology growing faster?
Coherus Oncology is growing faster (+40% against +9% a year earlier).
Which is more profitable, Champions Oncology or Coherus Oncology?
Champions Oncology is more profitable, with an operating margin of -2.7% against -226.0%.
More: Champions Oncology earnings · how Champions Oncology makes money · Coherus Oncology earnings · how Coherus Oncology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Sep 11, 2026; 10-Q filed Aug 5, 2026). Fiscal quarters can end on different dates. Not investment advice.